Management of medication overuse headache: 1-year randomized multicentre open-label trial

Cephalalgia

Volumn 29, Issue 2, 2009, Pages 221-232

  Hagen, K ^a,b   Albretsen, C ^c   Vilming, S T ^d   Salvesen, R ^e,f   Gronning M ^g   Helde, G ^a,b   Gravdahl, G ^a,b   Zwart, J A ^a,b,d   Stovner, L J ^a,b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^d UNIVERSITY OF TROMSØ   (Norway)

^e ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^f NORDLAND HOSPITAL   (Norway)

^g HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Discontinuation; Medication overuse headache; Prophylactic treatment

Indexed keywords

AMITRIPTYLINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CANDESARTAN; DICLOFENAC; GABAPENTIN; METOCLOPRAMIDE; NAPROXEN; VALPROIC ACID;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DETOXIFICATION; DISABILITY; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANALGESICS; ANALGESICS, OPIOID; FEMALE; HEADACHE DISORDERS, SECONDARY; HUMANS; MALE; MIGRAINE DISORDERS; RANDOM ALLOCATION; TENSION-TYPE HEADACHE; TREATMENT OUTCOME; TRYPTAMINES;

EID: 58449103368     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2008.01711.x     Document Type: Article

References (21)

1. Diener HC, Limmroth L. Medication-overuse headache: a worldwide problem. Lancet Neurol 2004 3 : 475 83.
2. Zwart JA, Dyb G, Hagen K, Svebak S, Stovner LJ, Holmen J. Analgesic overuse among subjects with headache, neck and low-back pain. Neurology 2004 62 : 1540 4.
3. Lu SR, Fuh JL, Chen WT, J uang KD, Wang SJ. Chronic daily headache in Taipei, Taiwan: prevalence, follow-up and outcome predictors. Cephalalgia 2001 21 : 980 6.
4. Wang SJ, Fuh JL, Liu CY, Hsu LC, Wang PN, Liu HC. Chronic daily headache in Chinese elderly. Prevalence, risk factors, and biannual follow-up. Neurology 2000 54 : 314 19.
5. Castillo J, Muñoz P, Guitera V, Pascual J. Epidemiology of chronic daily headache in the general population. Headache 1999 39 : 190 6.
6. Colás R, Muñoz P, Temprano R, Gómez C, Pascual J. Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology 2004 62 : 1338 42.
7. Bekkelund SI, Salvesen R. Drug-associated headache is unrecognized in patients treated at a neurological centre. Acta Neurol Scand 2002 105 : 120 3.
8. Olesen J, Bousser MG, Diener HC, Dodck D, First M, Goadsby PJ et al., Headache Classification Committee. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006 26 : 742 6.
9. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004 24 (Suppl. 1 88 101.
10. Silberstein S, Olesen J, Bousser MG, Diener HC, Dodick D, First M et al., on behalf of the International Headache Society. The International Classification of Headache Disorders, 2nd edition (ICHD-II) - revision of criteria for 8.2 Medication-overuse headache. Cephalalgia 2005 460 5.
11. Zeeberg P, Olesen J, Jensen R. Probable medication-overuse headache: the effect of a 2-month drug-free period. Neurology 2006 66 : 1894 8.
12. Good clinical practice: consolidated guideline WWW document]. URL http://www.ich.org [Last accessed 14 January 2008].
13. Herrmann C. International experiences with the hospital anxiety and depression scale - a review of validation data and clinical results. J Psychosom Res 1997 42 : 17 41.
14. Ware J, Kosinski M, Keller S. A 12-item short form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996 53 : 220 33.
15. Linton-Dahlöf P, Linde M, Dahlöf C. Withdrawal therapy improves chronic daily headache associated with long-term misuse of headache medication: a retrospective study. Cephalalgia 2000 20 : 658 62.
16. Perneger TV. What's wrong with Bonferroni adjustments. BMJ 1998 316 : 1236 8.
17. Schulz KF, Grimes DA. Multiplicity in randomized trials: endpoints and treatments. Lancet 2005 365 : 1591 5.
18. Diener HC, Bussone G, van Oene JC, Lahaye M, Schwalen S, Goadsby PJ. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia 2007 27 : 814 23.
19. Rossi P, Di Lorenzo C, Faroni J, Cesarino F, Nappi G. Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia 2006 26 : 1097 105.
20. Mei D, Ferraro D, Zelano G, Capuano A, Vollone C, Gabriele C, Di Trapani G. Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine. Clin Neuropharacol 2006 29 : 269 75.
21. Zeeberg P, Olesen J, Jensen R. Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia 2006 26 : 1192 8.